ClinicaliQ Trial Snapshot
- An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly — Recruiting • NCT07583563.
- Long-term study showing octreotide depot injections safely and effectively control acromegaly symptoms in routine clinical practice over two years.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The purpose of this study is to collect long-term (up to two years) safety and effectiveness of octreotide subcutaneous depot in patients with acromegaly in the real-world setting. Conditions: Acromegaly Interventions: Octreotide subcutaneous depot Lead Sponsor: Camurus AB Planned Enrollment: 200 participants